ATP2A2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Also known as: AT2A2_HUMAN, ATP2B, DAR, SERCA2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16615
- Gene
- ATP2A2
- Ensembl
- ENSG00000174437
- Chromosome
- 12
- Canonical length
- 1042 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Plasma membrane,Primary cilium,Perinuclear theca,Mid piece,End piece
OverviewNCBI Gene
This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of the skeletal muscle. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol into the sarcoplasmic reticulum lumen, and is involved in regulation of the contraction/relaxation cycle. Mutations in this gene cause Darier-White disease, also known as keratosis follicularis, an autosomal dominant skin disorder characterized by loss of adhesion between epidermal cells and abnormal keratinization. Other types of mutations in this gene have been associated with various forms of muscular dystrophies. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]
Canonical amino-acid sequenceUniProt
1042 residues, UniProt reviewed canonical sequence.
>P16615|ATP2A2
1 MENAHTKTVE EVLGHFGVNE STGLSLEQVK KLKERWGSNE LPAEEGKTLL ELVIEQFEDL
61 LVRILLLAAC ISFVLAWFEE GEETITAFVE PFVILLILVA NAIVGVWQER NAENAIEALK
121 EYEPEMGKVY RQDRKSVQRI KAKDIVPGDI VEIAVGDKVP ADIRLTSIKS TTLRVDQSIL
181 TGESVSVIKH TDPVPDPRAV NQDKKNMLFS GTNIAAGKAM GVVVATGVNT EIGKIRDEMV
241 ATEQERTPLQ QKLDEFGEQL SKVISLICIA VWIINIGHFN DPVHGGSWIR GAIYYFKIAV
301 ALAVAAIPEG LPAVITTCLA LGTRRMAKKN AIVRSLPSVE TLGCTSVICS DKTGTLTTNQ
361 MSVCRMFILD RVEGDTCSLN EFTITGSTYA PIGEVHKDDK PVNCHQYDGL VELATICALC
421 NDSALDYNEA KGVYEKVGEA TETALTCLVE KMNVFDTELK GLSKIERANA CNSVIKQLMK
481 KEFTLEFSRD RKSMSVYCTP NKPSRTSMSK MFVKGAPEGV IDRCTHIRVG STKVPMTSGV
541 KQKIMSVIRE WGSGSDTLRC LALATHDNPL RREEMHLEDS ANFIKYETNL TFVGCVGMLD
601 PPRIEVASSV KLCRQAGIRV IMITGDNKGT AVAICRRIGI FGQDEDVTSK AFTGREFDEL
661 NPSAQRDACL NARCFARVEP SHKSKIVEFL QSFDEITAMT GDGVNDAPAL KKAEIGIAMG
721 SGTAVAKTAS EMVLADDNFS TIVAAVEEGR AIYNNMKQFI RYLISSNVGE VVCIFLTAAL
781 GFPEALIPVQ LLWVNLVTDG LPATALGFNP PDLDIMNKPP RNPKEPLISG WLFFRYLAIG
841 CYVGAATVGA AAWWFIAADG GPRVSFYQLS HFLQCKEDNP DFEGVDCAIF ESPYPMTMAL
901 SVLVTIEMCN ALNSLSENQS LLRMPPWENI WLVGSICLSM SLHFLILYVE PLPLIFQITP
961 LNVTQWLMVL KISLPVILMD ETLKFVARNY LEPGKECVQP ATKSCSFSAC TDGISWPFVL
1021 LIMPLVIWVY STDTNFSDMF WSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 2,676 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 2,676 nTPM
- tongue: 2,586 nTPM
- heart muscle: 942 nTPM
- esophagus: 171 nTPM
- prostate: 88 nTPM
- urinary bladder: 85 nTPM
Single-cell type
- myonuclei: 3,843 nCPM
- cardiomyocytes: 1,388 nCPM
- endometrial ciliated cells: 881 nCPM
- endometrial glandular cells: 650 nCPM
- thymic myoid cells: 609 nCPM
- endometrial luminal cells: 509 nCPM
Immune cell
- intermediate monocyte: 1.3 nTPM
- non-classical monocyte: 0.7 nTPM
- classical monocyte: 0.6 nTPM
- gdT-cell: 0.5 nTPM
- myeloid DC: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
Brain region
- thalamus: 205 nTPM
- midbrain: 179 nTPM
- hippocampal formation: 161 nTPM
- cerebellum: 155 nTPM
- white matter: 152 nTPM
- basal ganglia: 150 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP2A2.
Disease | AllUniProt
Conditions ATP2A2 is implicated in, by any mechanism.
- Acrokeratosis verruciformis (AKV) MIM:101900
- Darier disease (DD) MIM:124200
- Rhabdomyolysis 2 (RHABDO2) MIM:621236
Disease | GeneticClinVar
93 pathogenic / likely-pathogenic of 413 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Keratosis follicularis
- ATP2A2-related disorder
- Acrokeratosis verruciformis of Hopf
- Darier disease, acral hemorrhagic type
- Darier disease, segmental
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.88
- DepMap mean gene effect
- -1.71
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- autophagosome membrane docking
- calcium ion import into sarcoplasmic reticulum
- calcium ion transmembrane transport
- calcium ion transport from cytosol to endoplasmic reticulum
- cardiac muscle hypertrophy in response to stress
- cell adhesion
- cellular response to oxidative stress
- endoplasmic reticulum calcium ion homeostasis
- epidermis development
- intracellular calcium ion homeostasis
- mitochondrion-endoplasmic reticulum membrane tethering
- monoatomic ion transmembrane transport
- negative regulation of heart contraction
- neuron cellular homeostasis
- organelle localization by membrane tethering
- positive regulation of cardiac muscle cell apoptotic process
- positive regulation of endoplasmic reticulum calcium ion concentration
- positive regulation of heart rate
- regulation of calcium ion-dependent exocytosis of neurotransmitter
- regulation of cardiac conduction
- regulation of cardiac muscle cell action potential involved in regulation of contraction
- regulation of cardiac muscle cell membrane potential
- regulation of cardiac muscle contraction by calcium ion signaling
- regulation of the force of heart contraction
- relaxation of cardiac muscle
- response to endoplasmic reticulum stress
- sarcoplasmic reticulum calcium ion transport
- T-tubule organization
- transition between fast and slow fiber
- ER-nucleus signaling pathway
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium channel regulator activity
- calcium ion binding
- enzyme binding
- lncRNA binding
- P-type calcium transporter activity
- S100 protein binding
- transmembrane transporter binding
- P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- P-type ATPase, subfamily IIA, SERCA-type
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP2A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2A2 as an antibody target. Whether an autoantibody or antibody against ATP2A2 could matter depends on whether native ATP2A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP2A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...